FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 40 filers reported holding FORTRESS BIOTECH INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -87.5% | 5,032 | -67.8% | 0.00% | – |
| Q2 2023 | $8 | +166.7% | 15,624 | +266.7% | 0.00% | – |
| Q1 2023 | $3 | -100.0% | 4,261 | -89.1% | 0.00% | – |
| Q4 2021 | $97,000 | +4750.0% | 39,036 | +2791.6% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 1,350 | -32.5% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 2,000 | +3.2% | 0.00% | – |
| Q3 2018 | $3,000 | -70.0% | 1,938 | -44.6% | 0.00% | – |
| Q2 2018 | $10,000 | +150.0% | 3,497 | +288.6% | 0.00% | – |
| Q1 2018 | $4,000 | – | 900 | +1400.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 60 | -96.1% | 0.00% | – |
| Q3 2017 | $6,000 | -83.8% | 1,543 | -89.0% | 0.00% | -100.0% |
| Q4 2016 | $37,000 | 0.0% | 13,991 | +10.5% | 0.00% | -33.3% |
| Q3 2016 | $37,000 | +3600.0% | 12,663 | +2565.9% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 475 | +17.9% | 0.00% | – |
| Q1 2016 | $1,000 | -80.0% | 403 | -80.7% | 0.00% | – |
| Q4 2015 | $5,000 | – | 2,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Belmont Global Advisors, Inc. | 550,000 | $1,479,000 | 1.42% |
| Avoro Capital Advisors LLC | 1,326,636 | $3,569,000 | 0.79% |
| Geduld E E | 10,000 | $27,000 | 0.04% |
| ELLIOTT MANAGEMENT CORP | 1,074,707 | $2,891,000 | 0.02% |
| HighPoint Advisor Group LLC | 14,230 | $42,000 | 0.02% |
| Acrospire Investment Management LLC | 7,179 | $19,000 | 0.01% |
| B. Riley Wealth Advisors, Inc. | 24,100 | $65,000 | 0.01% |
| ClariVest Asset Management LLC | 117,719 | $316,000 | 0.01% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 15,985 | $43,000 | 0.01% |
| DENVER INVESTMENT ADVISORS LLC | 26,908 | $72,000 | 0.00% |